PT94084A - Processo para a preparacao den n-(ariloxialquil)-heteroarilpiperidinas e - heteroarilpiperazinas e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao den n-(ariloxialquil)-heteroarilpiperidinas e - heteroarilpiperazinas e de composicoes farmaceuticas que os contem

Info

Publication number
PT94084A
PT94084A PT94084A PT9408490A PT94084A PT 94084 A PT94084 A PT 94084A PT 94084 A PT94084 A PT 94084A PT 9408490 A PT9408490 A PT 9408490A PT 94084 A PT94084 A PT 94084A
Authority
PT
Portugal
Prior art keywords
lower alkyl
alkyl
chem
alkoxy
hydrogen
Prior art date
Application number
PT94084A
Other languages
English (en)
Other versions
PT94084B (pt
Inventor
Grover C Helsley
Joseph T Strupczewski
Kenneth J Bordeau
Yulin Chiang
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of PT94084A publication Critical patent/PT94084A/pt
Publication of PT94084B publication Critical patent/PT94084B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
PT94084A 1989-05-19 1990-05-18 Processo para a preparacao den n-(ariloxialquil)-heteroarilpiperidinas e - heteroarilpiperazinas e de composicoes farmaceuticas que os contem PT94084B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35441189A 1989-05-19 1989-05-19
US45679089A 1989-12-29 1989-12-29

Publications (2)

Publication Number Publication Date
PT94084A true PT94084A (pt) 1991-01-08
PT94084B PT94084B (pt) 1996-12-31

Family

ID=26998389

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94084A PT94084B (pt) 1989-05-19 1990-05-18 Processo para a preparacao den n-(ariloxialquil)-heteroarilpiperidinas e - heteroarilpiperazinas e de composicoes farmaceuticas que os contem

Country Status (24)

Country Link
EP (1) EP0402644B1 (pt)
JP (1) JPH0662580B2 (pt)
KR (1) KR0157308B1 (pt)
CN (2) CN1086387C (pt)
AT (1) ATE126512T1 (pt)
AU (1) AU640653B2 (pt)
CA (1) CA2017193C (pt)
CZ (1) CZ282385B6 (pt)
DD (1) DD300433A5 (pt)
DE (1) DE69021645T2 (pt)
DK (1) DK0402644T3 (pt)
ES (1) ES2076253T3 (pt)
FI (2) FI104072B (pt)
GR (1) GR3017447T3 (pt)
HK (2) HK1006710A1 (pt)
HU (2) HU218200B (pt)
IE (1) IE68431B1 (pt)
IL (1) IL94425A (pt)
NO (1) NO177301C (pt)
NZ (1) NZ233710A (pt)
PL (1) PL163965B1 (pt)
PT (1) PT94084B (pt)
RU (3) RU2062776C1 (pt)
SK (1) SK279474B6 (pt)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561128A (en) * 1989-05-19 1996-10-01 Hoechst-Roussel Pharmaceuticals, Inc. N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
DK203990D0 (da) * 1990-08-24 1990-08-24 Novo Nordisk As Piperazinylderivater
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
TW241263B (pt) * 1991-08-22 1995-02-21 Hoechst Roussel Pharma
NZ240863A (en) * 1991-09-11 1995-04-27 Mcneilab Inc Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof
JPH07502268A (ja) * 1991-11-27 1995-03-09 ノボ ノルディスク アクティーゼルスカブ 化学化合物、それらの製法および使用
US5378714A (en) * 1991-11-27 1995-01-03 Novo Nordisk A/S Antipsychotic piperidine derivatives
AU3170793A (en) * 1991-12-25 1993-07-28 Zeria Pharmaceutical Co., Ltd. Tricyclic compound and medicine containing the same
EP0665840A1 (en) * 1992-10-23 1995-08-09 MERCK SHARP & DOHME LTD. Dopamine receptor subtype ligands
US5631269A (en) * 1992-10-23 1997-05-20 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands
DK60593D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
DK60793D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
GB9318691D0 (en) * 1993-09-09 1993-10-27 Merck Sharp & Dohme Therapeutic agents
EP0724572B1 (en) * 1993-09-15 1998-12-16 MERCK SHARP & DOHME LTD. Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
ES2101646B1 (es) * 1995-04-12 1998-04-01 Ferrer Int Nuevo compuesto derivado del cromeno.
US5668148A (en) * 1995-04-20 1997-09-16 Merck & Co., Inc. Alpha1a adrenergic receptor antagonists
MX9709451A (es) * 1995-06-06 1998-02-28 Hoechst Marion Roussel Inc Derivados de benzisoxazol e indazol como agentes antipsicoticos.
AU710059B2 (en) * 1996-01-05 1999-09-09 Aventis Pharmaceuticals Inc. 4,5-dihydronaphth(1,2-C)isoxazoles and derivatives thereof having CNS activity
US5880121A (en) * 1996-01-05 1999-03-09 Hoechst Marion Roussel Inc. 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof
ES2144355B1 (es) * 1997-12-30 2001-01-01 Ferrer Int Compuestos derivados del cromeno.
AU7547100A (en) * 1999-09-09 2001-04-10 Egis Gyogyszergyar Rt. Alkylpiperidi nylbenzo [d] isoxazole derivatives having psychotropic activity, pharmaceutical compositions containing the same, and a process for the preparation of the active ingredient
GB0102841D0 (en) * 2001-02-05 2001-03-21 Novartis Ag Organic compounds
AU2006201188B2 (en) * 2001-02-05 2007-11-15 Novartis Ag New use of iloperidone
ATE518845T1 (de) * 2001-08-31 2011-08-15 Novartis Pharma Gmbh Optische isomere eines iloperidon-metaboliten
EP2295058B1 (en) 2001-10-30 2013-09-04 Novartis AG Depot formulations of iloperidone with a polymer
US6995144B2 (en) * 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
GB0216416D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
AP2005003250A0 (en) * 2002-09-17 2005-03-31 Warner Lambert Co Heterocyclic substituted piperazines for the treatment of schizophrenia.
JP2006508101A (ja) * 2002-11-08 2006-03-09 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー フェニルアルキルおよびピリジルアルキルピペラジン誘導体
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
GB0322994D0 (en) * 2003-10-01 2003-11-05 Novartis Ag Organic compounds
MX2008010481A (es) 2006-02-17 2008-12-19 Memory Pharm Corp Compuestos que tienen afinado para el receptor f-ht6.
WO2008066750A1 (en) 2006-11-22 2008-06-05 Seaside Therapeutics, Llc Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism
WO2008128166A1 (en) * 2007-04-13 2008-10-23 Concert Pharmaceuticals Inc. Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
CN101824030B (zh) * 2009-03-04 2014-06-18 北京德众万全药物技术开发有限公司 一种伊潘立酮的制备方法
WO2010151689A1 (en) 2009-06-25 2010-12-29 Alkermes, Inc. Heterocyclic compounds for the treatment of neurological and psychological disorders
US8802855B2 (en) 2009-09-19 2014-08-12 Zhejiang Huahai Pharmaceutical Co., Ltd. Method for preparation of iloperidone and crystallization method thereof
CN102030744B (zh) * 2009-09-30 2013-04-17 天津药物研究院 伊潘立酮晶体、其制备方法及药物组合物
WO2011061750A2 (en) * 2009-11-19 2011-05-26 Symed Labs Limited Process for the preparation of iloperidone using a novel intermediate
WO2011154860A1 (en) * 2010-06-08 2011-12-15 Alembic Pharmaceuticals Limited An improved process for preparing iloperidone
CN102311430A (zh) * 2010-06-29 2012-01-11 大道隆达(北京)医药科技发展有限公司 伊潘立酮的新晶态及其制备方法
ITMI20101294A1 (it) * 2010-07-14 2012-01-15 Dipharma Francis Srl Procedimento per la preparazione di iloperidone
WO2012032532A1 (en) * 2010-09-07 2012-03-15 Symed Labs Limited "processes for the preparation of 4'-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino]propoxy]-3'-methoxyacetophenone and intermediates thereof"
WO2012063269A2 (en) 2010-11-12 2012-05-18 Cadila Healthcare Limited Process for preparing iloperidone
EP3034079B1 (en) 2010-11-15 2018-01-10 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
WO2012123963A2 (en) 2011-02-24 2012-09-20 Megafine Pharma (P) Ltd. A process for preparation of iloperidone and amorphous co- precipitate of iloperidone with pharmaceutically acceptable excipient
WO2012153341A1 (en) 2011-05-12 2012-11-15 Arch Pharmalabs Limited A process for the preparation of iloperidone and pharmaceutically acceptable salts thereof
WO2012164516A1 (en) 2011-06-03 2012-12-06 Lupin Limited Process for the preparation of iloperidone
ITMI20120511A1 (it) * 2012-03-29 2013-09-30 Procos Spa Processo one-pot per la sintesi di iloperidone
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
AU2014368961B2 (en) 2013-12-20 2019-10-17 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
IL256354B (en) 2015-06-19 2022-09-01 Agenebio Inc History of benzodiazepines, preparations and their use for the treatment of cognitive impairment
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio Inc derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
WO2019246300A1 (en) 2018-06-19 2019-12-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20240132513A1 (en) 2022-08-19 2024-04-25 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4458076A (en) * 1983-05-31 1984-07-03 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidinyl)-1,2-benzisothiazoles
HU198036B (en) * 1983-08-22 1989-07-28 Hoechst Roussel Pharma Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives

Also Published As

Publication number Publication date
NZ233710A (en) 1992-05-26
JPH0662580B2 (ja) 1994-08-17
JPH0363263A (ja) 1991-03-19
CN1048037A (zh) 1990-12-26
RU2062776C1 (ru) 1996-06-27
NO177301C (no) 1995-08-23
CN1223348C (zh) 2005-10-19
RU2147583C1 (ru) 2000-04-20
FI104072B1 (fi) 1999-11-15
HK1006710A1 (en) 1999-03-12
ATE126512T1 (de) 1995-09-15
IE68431B1 (en) 1996-06-12
PL163965B1 (pl) 1994-05-31
GR3017447T3 (en) 1995-12-31
AU5577090A (en) 1990-11-22
DE69021645D1 (de) 1995-09-21
PL285247A1 (en) 1991-02-11
IL94425A0 (en) 1991-03-10
SK242590A3 (en) 1998-11-04
RU2239434C2 (ru) 2004-11-10
DK0402644T3 (da) 1996-01-02
NO902214D0 (no) 1990-05-18
HU218200B (hu) 2000-06-28
CZ242590A3 (en) 1997-03-12
HU903090D0 (en) 1990-09-28
PT94084B (pt) 1996-12-31
ES2076253T3 (es) 1995-11-01
CA2017193A1 (en) 1990-11-19
EP0402644B1 (en) 1995-08-16
HUT58720A (en) 1992-03-30
IL94425A (en) 1994-02-27
FI902449A0 (fi) 1990-05-17
NO177301B (no) 1995-05-15
NO902214L (no) 1990-11-20
EP0402644A1 (en) 1990-12-19
CZ282385B6 (cs) 1997-07-16
CN1305812A (zh) 2001-08-01
FI104072B (fi) 1999-11-15
FI19991869A (fi) 1999-09-02
CA2017193C (en) 2000-06-27
IE901809L (en) 1990-11-19
KR900018070A (ko) 1990-12-20
DE69021645T2 (de) 1996-02-22
AU640653B2 (en) 1993-09-02
HU211853A9 (en) 1995-12-28
HK1038316A1 (en) 2002-03-15
SK279474B6 (sk) 1998-11-04
CN1086387C (zh) 2002-06-19
DD300433A5 (de) 1992-06-11
KR0157308B1 (ko) 1998-11-16

Similar Documents

Publication Publication Date Title
PT94084A (pt) Processo para a preparacao den n-(ariloxialquil)-heteroarilpiperidinas e - heteroarilpiperazinas e de composicoes farmaceuticas que os contem
PT90805A (pt) Processo para a preparacao de 1-indolilalquil-4-(piridinil substituido)-piperazinas e de composicoes farmaceuticas que as contem
AU5060490A (en) 2-(1-piperazinyl)-4-phenylcycloalkano-pyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same
MX9202142A (es) Nuevos derivados de urea, proceso para su preparacion, y composicion farmaceutica que los comprende.
PT787726E (pt) Novo composto, processo para a sua producao e agente tumoral
PT96324A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
ATE236882T1 (de) Bicyklische fibrinogen antagoniste
BR1100514A (pt) Processo para a preparação de compostos derivados do ácido benzimidazolino - 2 - oxo - 1 - carboxìlico; produto / composto / composição
DE69310501D1 (de) Chinolylbenzofuran derivate als leukotrien-antagonisten
PT98114A (pt) Processo para a prparacao de 1-indolilalquil-4-(alcoxipirimidinil)piperazinas e de composicoes farmaceuticas que as contem
ES2118364T3 (es) Derivados de acido hidroxietilamino-sulfamico utiles como inhibidores de proteasas retroviricas.
PT98362A (pt) Processo para a preparacao de derivados de tioalquiltio-cefalosporina e de composicoes farmaceuticas que os contem
PT90725A (pt) Processo para a preparacao de novos compostos cefem
PT90269A (pt) Processo para a preparacao de carboxamidas hetero-alifaticas e de composicoes farmaceuticas que as contem
PT91932A (pt) Processo de preparacao de derivados substituidos da piperazina e de preparados farmaceuticos que os contem
HUT63159A (en) Process for producing tokoferol derivatives and pharmaceutical compositions comprising same as active ingredient
RS49829B (sr) Postupak i intermedijeri za proizvodnju piridin-2,3-dikarboksilat jedinjenja
ATE149494T1 (de) Benzopyranderivate und verfahren zu deren herstellung
PT87162A (pt) Process for the preparation of a pyridil alcanoic acid compoundcontainig a sulphonamido group and of pharmaceutical compositions therewith
DE3688161D1 (de) Gegebenenfalls etherifizierte oder esterifizierte in stellung 2 substituierte 4-oh-chinolincarbonsaeurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
DE69316392D1 (de) Azanoradamantane
IE820160L (en) Heterocyclic benzamide derivatives

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960918

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20110919